TRANSCODE THERAPEUTICS INC (RNAZ) Institutional Ownership and Insiders Activity

TRANSCODE THERAPEUTICS INC (RNAZ) is widely held by institutional investors, with 9 firms reporting positions valued at approximately $208,017 based on SEC Form 13F filings for the quarter ended June 30, 2026.

Yorkville Advisors Global, Lp is the largest disclosed holder, reporting approximately $121,958 in RNAZ holdings in its latest filing.

Institutional ownership remains highly concentrated, with Yorkville Advisors Global, Lp representing the majority of disclosed value.